Clinical Trials in Detroit

Showing 7041-7060 of 19,719 trials

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

NCT04377945

This is a two-part, double-blind, placebo-controlled, randomized, multicenter Phase 2 clinical trial of JM-010 in patients with Parkinson's Disease.

DyskinesiasParkinson Disease

Bukwang Pharmaceutical41 participantsStarted Apr 2021

Miami, Florida, United States • Detroit, Michigan, United States

Active Not RecruitingNA30 miles

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

NCT04191330

The goal of this real-world, multi-center, randomized, outpatient study is to assess the effectiveness of the Biofourmis cloud based BiovitalsHF platform to recommend optimal titration of Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF) subjects.

Heart Failure

Biofourmis Inc.122 participantsStarted Jan 2020

Little Rock, Arkansas, United States • Washington D.C., District of Columbia, United States • Athens, Georgia, United States +11 more locations

Study in Parkinson's Disease Patients With Dyskinesia With Combinations of JM-010 and Its Individual Components

Artificial Intelligence Mobile Health Trial Of A Digital Platform To Optimize GDMT Using Wearable Sensors

Find Trials by Condition in Detroit

Open-Label Study of Oral Treprostinil in Digital Ulcers

Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery

Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Participants With Wilson Disease

Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients

Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

Expanded Access Protocol of Teprotumumab (HZN-001) for Patients With Active Thyroid Eye Disease

Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer

Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

A Study to Determine Safety of Durvalumab After Sequential Chemo Radiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

A Study of Replagal in Treatment-naïve Adults With Fabry Disease

Study of the Safety and Efficacy of LHC165 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies